Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|FGFR2 - BICC1||cholangiocarcinoma||sensitive||AZD4547||Preclinical - Cell culture||Actionable||In a preclinical study, cholangiocarcinoma cell lines expressing FGFR2-BICC1 were sensitive to treatment with AZD4547 in culture, demonstrating decreased cell viability, and suppression of Erk and Mapk phosphorylation (PMID: 33692336).||33692336|